About Omnicell
Omnicell is a publicly listed company based in Mountain View (United States) founded in 1992 by Randy Lipps. Materials management and business analytics solutions for healthcare are provided. It operates on a SaaS (Software-as-a-Service), Professional Services, and HealthTech model. Omnicell has raised $20 million across 3 funding rounds from investors including Mariko Osceola Gordon, Sutter Hill Ventures and nassau-capital.com. The company has 3,670 employees. Omnicell has completed 10 acquisitions, including Aesynt, Ateb and FDS Amplicare. Its chief executive, as recorded, is Randy Lipps. Its website omnicell.com draws about 95 thousand monthly visits. Its Indian entity Omnicell India Private Limited reported revenue of ₹77.68 Cr. Omnicell offers products and services including MedVision, Robotics, Smart Devices, and Services. Its focus areas include Health Technology and Medication Management. Its competitors include GE Healthcare, Cureatr and Phil; 3 of its 3 listed competitors have raised funding.
Company details
Omnicell is engaged in providing innovative solutions for pharmacy and medication management across various healthcare settings. The company operates in inpatient, outpatient, specialty, and retail pharmacy sectors. Solutions offered include robotics for automation, smart devices for workflow efficiency, software for supply chain visibility, and professional services to enhance operational value. Omnicells technology is designed to support health systems in achieving cost savings, improving efficiency, gaining supply chain control, and ensuring compliance. The focus remains on delivering outcomes-centric innovation to transform pharmacy care.
- Headquarters Mountain View, United States
- Employees 3,670
- Founders Randy Lipps
- Stage Public
- SectorsHealthcare
- Website omnicell.com
- Social LinkedIn X Facebook
- Legal Name Omnicell, Inc.
- Indian entity revenue₹77.68 Cr
FY 2025 · +63% YoY
- Indian entity net profit₹6.97 Cr
FY 2025 · 9% margin
- Indian entity EBITDA₹10.73 Cr
FY 2025 · 14% margin
- Total Equity Funding$20M (USD)
in 3 rounds
- InvestorsSutter Hill Ventures
& 4 more
- Employee Count3,670
- Investments & AcquisitionsAesynt
& 9 more
Associated legal entities of Omnicell
Omnicell operates through Omnicell India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Omnicell India Private Limited CIN U74999KA2021FTC147750 | Active | 22 May 2021 | Bangalore, Karnataka | ₹77.7 Cr | 96 | 3 | View details |
Products & Services of Omnicell
Omnicell offers a comprehensive portfolio of products and services, including MedVision, Robotics, Smart Devices, and Services.
Software designed to manage medications in remote clinics.
Robotics used to automate medication management processes.
Devices built to streamline workflows for patient care.
Services provided to enhance pharmacy technology value.
Funding Insights of Omnicell
Omnicell has successfully raised a total of $20M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $20M
- Total Rounds 3
- Investors Count 5
All 3 funding rounds of Omnicell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2017 | Post-IPO | – | – | ||
| Feb 2000 | $20M | Series B | – | ABS Capital | |
| Jun 1995 | Unspecified | – | – |
5 investors in total: 4 institutional and 1 angel.
Investors in Omnicell
Omnicell has secured backing from 5 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Mariko Osceola Gordon, Sutter Hill Ventures and nassau-capital.com.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm investing in the US | shv.com | Palo Alto, United States | ||
| abscapital.com | ||||
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | ||
| nassau-capital.com | ||||
MO Mariko Osceola Gordon | unknown_181eb2ebe605431eb |
Investor details for Omnicell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Omnicell India Private Limited (Omnicell)
Omnicell India Private Limited is the primary company behind Omnicell. The board of Omnicell India Private Limited currently have 3 directors; the longest-serving is Steven Gary Humphreys, appointed in 2024. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Steven Gary Humphreys DIN 10555277 | Director | 26 Mar 2024 | 2 yrs 7 mo | Omnicell India Private Limited |
| Brian Henry Nutt DIN 10632471 | Director | 21 May 2024 | 2 yrs 5 mo | Omnicell India Private Limited |
| Ananta Ramamurthy Deshpande DIN 08238355 | Director | 28 Feb 2025 | 1 yr 8 mo | Omnicell India Private Limited |
People of Omnicell
431 people are tracked at Omnicell (119 in leadership, 9 in board & advisors, 303 in team); the tracked headcount is 3,670.
| Name | Role | Group |
|---|---|---|
Randy Lipps | Founder & CEO | Leadership |
Nnamdi Njoku | EVP & Chief Operating Officer | Leadership |
Jason Curtis | Sr. Director, Technical Services | Leadership |
Joshua J. Shepherd | Senior Global Business Planning Analyst - Finance, Global Supply Chain VP | Leadership |
Vicki MacDevitt | Chief of Staff | Leadership |
Tomer Stavitsky | Svp, Chief Corporate Development Officer | Leadership |
McKenzie Mack | Director Of Market Development- Medication Adherence | Leadership |
Terry Harris | Director - Pharmacy Optimization, Med Adherence | Leadership |
Madeline Meyer | Director | 340b Operations, Client Strategy & Program Optimization | Leadership |
Nchacha Etta | EVP & Chief Financial Officer | Leadership |
Thomas Weiland | Sales Director | Leadership |
Francois Verdeaux | Vice President & General Manager, International | Leadership |
Twinklekumar Patel | Technical Director, Global AI Transformation | Leadership |
Corey Manley | EVP & Chief Legal & Administrative Officer | Leadership |
Tim Kane | Director Of Product Management | Leadership |
Baird Radford | Chief Financial Officer | Leadership |
Randall A. Lipps | Founder, Chairman, President & CEO | Leadership |
Bob Meek | Sr. Director, Engineering Services | Leadership |
Joe Spears | CAO, Corporate Controller & VP, Corporate Finance | Leadership |
Mike Depinto | Global Procurement Director | Leadership |
411 more people are available in the full profile.
Complete people profiles for Omnicell
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Omnicell
Omnicell is a publicly listed company on the NASDAQ with ticker symbol OMCL in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Aug 2001
- Listed onNASDAQ: OMCL
- Listed entityOmnicell, Inc.
- Exchange sectorTechnology services
- ISINUS68213N1090
- Share price$36.45 (-1.14% on the day) · 2026-10-13
- Market capitalisation$1.66B
- Price to earnings43.1
- EPS (diluted, trailing year)$0.85
- Volume (last session)400,770
Financials of Omnicell
Figures of Omnicell India Private Limited, the primary company behind Omnicell, for FY 2025. Revenue was ₹77.68 Cr (+63% year on year). Net profit was ₹6.97 Cr (9% margin). EBITDA was ₹10.73 Cr (14% margin). Revenue has grown at a compounded annual rate of +129% over three years.
- ₹77.68 CrRevenue · FY 2025 · +63% YoY
- ₹6.97 CrNet profit · 9% margin
- ₹10.73 CrEBITDA · 14% margin
- ₹1 LakhPaid-up capital
- 96Employees (provident fund records)
- +129%Revenue CAGR, 3 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $1.18B | $2.0M | $98.3M |
| 2024 | $1.11B | $12.5M | $95.2M |
| 2023 | $1.15B | -$20.4M | $76.2M |
| 2022 | $1.30B | $5.7M | $119.7M |
| 2021 | $1.13B | $77.8M | $187.2M |
Balance sheet, profit and loss, cash flow and ratios of Omnicell India Private Limited are on its company page.
Detailed financial statements for Omnicell
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Omnicell
Omnicell has strategically engaged in corporate development activities, having acquired 10 companies. Notable acquisitions include Aesynt, Ateb and FDS Amplicare.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of healthcare pharmacy services | pharmaself24.co.uk | Leicester, United Kingdom | 2018 | Jan 2022 | •••• | |
Communication solutions for retail pharmacies are automated via multiple channels. | marketouchmedia.com | Houston, United States | 2002 | Jan 2022 | $82M | |
Chain of drug stores | receptrx.com | Grapevine, United States | 1978 | Dec 2021 | $100M | |
Pharmacy management software is supplied to pharmaceutical professionals. | 0 | Sep 2021 | •••• | |||
Medication and supply management solutions for pharmacies are provided. | inpharmics.com | Madison, United States | 2011 | Apr 2017 | •••• | |
Pharmacy-based patient care solutions and medication synchronization are provided. | ateb.com | Raleigh, United States | 1992 | Nov 2016 | $41M | |
Provides pharmacy automation and information management solutions for hospitals and health systems. | aesynt.com | Cranberry Township, United States | 2013 | Oct 2015 | $275M | |
Medication and supply management services are provided via automation technology. | mach4.de | Bochum, Germany | 1997 | Feb 2015 | •••• | |
Developer of automated medication dispensing machine | mts-mt.com | St. Petersburg, United States | 1984 | May 2012 | $156M | |
Analytical software for hospital medication diversion detection is developed. | pandoradatasystems.com | Boston, United States | 1988 | Oct 2010 | •••• |
Complete acquisition details for Omnicell
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Omnicell
14 dated milestones of Omnicell across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Omnicell is founded.
- Funding First funding round.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Pandora Data Systems.
- Acquisition Acquires MTS Medication Technologies.
- Acquisition Acquires MACH4 Automation Technology.
- Acquisition Acquires Aesynt.
- Acquisition Acquires Ateb.
- Acquisition Acquires InPharmics.
- Funding Latest funding round, Post-IPO,.
- Acquisition Acquires FDS Amplicare.
- Acquisition Acquires ReCept Pharmacy.
- Acquisition Acquires Marketouch Media.
- Acquisition Acquires Pharmaself24.
Competitors of Omnicell
Omnicell has 3 listed competitors in our database, 3 of them funded. They include GE Healthcare, Cureatr and Phil.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gehealthcare.com | 1892 | Chicago, United States | $29.13M | 16,700 | Materials management solutions are provided for healthcare organizations. | |
| cureatr.com | 2011 | New York, United States | $40.75M | Cloud-based medication management software is provided for healthcare providers. | ||
| phil.us | 2015 | San Francisco, United States | $105.54M | 99 | Prescription drugs refill management solutions |
Detailed competitors of Omnicell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Omnicell
The website of Omnicell (omnicell.com) receives about 95.2K visits a month.
- Monthly visits95.2K
▲ 32.3% vs previous month
Websites whose visitors overlap most with Omnicell. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
cardinal.com | cardinal.com | 100% | #8,784,623 | – | |
scriptcalc.com | scriptcalc.com | 80% | #1,678,493 | – | |
datascope.com | datascope.com | 80% | – | ||
invernessmedical.com | invernessmedical.com | 76% | – | ||
| viropharma.com | 76% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Omnicell
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Omnicell (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Omnicell
Complete news archive for Omnicell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Omnicell
Omnicell was founded in 1992 and raised its 1st funding round 3 years after it was founded.
Omnicell is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Randy Lipps is the CEO of Omnicell, as recorded in our data. They have also founded this company.
Omnicell is a funded company, having raised a total of $20M across 3 funding rounds to date.
Omnicell has 3,670 employees.
The primary company behind Omnicell, Omnicell India Private Limited, reported revenue of ₹77.68 Cr for FY 2025, up 63% year on year.
Omnicell is engaged in providing innovative solutions for pharmacy and medication management across various healthcare settings. The company operates in inpatient, outpatient, specialty, and retail pharmacy sectors. Solutions offered include robotics for automation, smart devices for workflow efficiency, software for supply chain visibility, and professional services to enhance operational value. Omnicells technology is designed to support health systems in achieving cost savings, improving efficiency, gaining supply chain control, and ensuring compliance. The focus remains on delivering outcomes-centric innovation to transform pharmacy care.
Omnicell's top competitors include GE Healthcare, Phil and Cureatr.
Omnicell offers MedVision, Robotics, Smart Devices, and Services.
Yes, Omnicell is publicly traded on NASDAQ under the ticker symbol OMCL.
Omnicell has made 10 acquisitions, including Aesynt, Ateb, and FDS Amplicare.
Omnicell has 5 investors. Key investors include Mariko Osceola Gordon, Sutter Hill Ventures, nassau-capital.com, ABS Capital, and Sequoia Capital.